Latest Reports

The “2021 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. 

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.

The “2020 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2020 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, corneal inlays, refractive lens exchange (RLE), and other technologies that may disrupt the market.

On October 30, 2020, Market Scope invited 891 US ophthalmologists via our online survey portal to participate in part seven of a nine-part series of surveys to capture the impact of COVID-19 on ophthalmic practices. There were 117 participants, representing 33 states. This survey attracted a diverse group of doctors; 85 percent of respondents provide cataract surgery, 63 percent perform glaucoma surgery, 29 percent treat retina patients, and 31 percent provide cornea treatment. Most of these doctors offer multiple areas of treatment. All individual responses are kept strictly confidential, and we report only aggregate data.

The “2021 US Cataract Pharmaceuticals Market Report” offers an in-depth examination of the current cataract pharmaceuticals market in the United States and forecasts market performance over the next five years. The report includes analysis of current markets, identification of important trends, and discussion of key factors for future success.

Market Scope has been meticulously tracking the effects of COVID-19 on the ophthalmic industry since the onset. After surveying US practices throughout 2020, we recently began surveying in Europe to better understand the impact on patient backlog, surgical procedures, adoption of technology, patient selection, and much more more. Our "2021 European COVID-19 Ophthalmic Practice Impact Survey Report" summarizes those findings for industry and surgeons to gain valuable insight into the markets' recovery.

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time. The OMP provides perspective on products, events, and market trends, and timely information and analysis on the following:

• US cataract, refractive, glaucoma, and retinal procedure volumes
• Newly commercialized ophthalmic devices and pharmaceuticals
• Investigational technologies
• Economic issues affecting the ophthalmic industry and medical practice
• Yearly US regulatory updates on cataract, refractive, retinal, glaucoma, and dry eye devices and pharmaceuticals
• Presentations and developments at major ophthalmic meetings—the AAO, the ASCRS, ARVO, the ESCRS, and other key meetings
• Previews of significant agenda items at upcoming ophthalmic meetings
• Trends in the practice of ophthalmic medicine
• Mergers and acquisitions of ophthalmic companies
• Previews/summaries of newly published Market Scope comprehensive reports
• New surgical techniques
• Controversies affecting the ophthalmic industry
• Ophthalmic news from Europe, Japan, China, India, and other regions
• Shifts in the competitive landscape within ophthalmic market segments
• Retinal, glaucoma, and dry eye pharmaceuticals
• Briefs on new executive officers and other changes in top personnel
• And much more

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our US Retina Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Our coverage of the US glaucoma surgery market includes a quarterly surveying process that targets and collects data from glaucoma surgeons. The resulting data are analyzed and presented in our US Glaucoma Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, product use and market share, product adoption plans, and the identification of significant trends in the marketplace for the treatment of glaucoma. 

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

The 2021 Retinal Surgical Device Market Report provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2021 market and forecasts market growth and evolution through 2026.

The 2021 Glaucoma Pharmaceuticals Market Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceuticals segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and anyone else who might be interested in the global marketplace of glaucoma pharmaceuticals.